Back to Journals » Core Evidence » Volume 14

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy

Total article views   Abstract views HTML views PDF downloads Totals
3,490 Dovepress* 1,654 289+ 760 1,943
PubMed Central* 0 1,547 280 1,547
Totals 1,654 1,836 1,040 3,490
*Since 26 April 2019
+Since July 2016

View citations on PubMed Central and Google Scholar